Free Trial

Fate Therapeutics (FATE) SEC Filings & 10K Form

Fate Therapeutics logo
$2.02 -0.06 (-2.88%)
(As of 11/15/2024 ET)

Recent Fate Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
6:50 PM
Fate Therapeutics (Subject)
Point72 Asset Management, L.P. (Filed by)
Form SC 13G/A
10/25/2024
8:37 PM
Boxer Capital Management, LLC (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
08/30/2024
3:21 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:01 PM
Fate Therapeutics (Issuer)
Xu Yuan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
9:34 AM
Fate Therapeutics (Subject)
Xu Yuan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
4:59 PM
Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/31/2024
5:00 PM
Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:01 PM
Fate Therapeutics (Issuer)
Mozaffarian Neelufar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
5:05 PM
Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:03 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
5:19 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
5:20 PM
Fate Therapeutics (Issuer)
Lee Michael Stewart (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:35 PM
Fate Therapeutics (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:30 PM
Fate Therapeutics (Issuer)
Jooss Karin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
4:05 PM
Fate Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/10/2024
3:31 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2024
4:26 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
4:24 PM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
8:01 AM
Fate Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
11:15 PM
Fate Therapeutics (Filer)
Form EFFECT
04/26/2024
3:16 PM
Fate Therapeutics (Filer)
Form ARS
03/25/2024
8:30 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
4:15 PM
Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
03/20/2024
4:30 PM
Fate Therapeutics (Filer)
Form 424B5
03/04/2024
12:29 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2024
5:06 PM
Boxer Capital, LLC (Filed by)
Fate Therapeutics (Subject)
Form SC 13G
02/09/2024
5:19 PM
Capital World Investors (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
01/30/2024
3:01 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2024
12:44 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/24/2024
8:46 AM
BlackRock Inc. (Filed by)
Fate Therapeutics (Subject)
Form SC 13G/A
01/22/2024
12:46 PM
Fate Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/10/2024
3:29 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:29 PM
Fate Therapeutics (Issuer)
Wolchko J Scott (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:30 PM
Fate Therapeutics (Issuer)
Valamehr Bahram (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/10/2024
3:30 PM
Fate Therapeutics (Issuer)
TAHL CINDY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2024
3:35 PM
Fate Therapeutics (Subject)
Valamehr Bahram (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:36 PM
Fate Therapeutics (Subject)
TAHL CINDY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:36 PM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/09/2024
3:39 PM
Fate Therapeutics (Subject)
Wolchko J Scott (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/02/2024
11:17 AM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
12/28/2023
8:30 PM
Fate Therapeutics (Issuer)
Green Jeremy (Reporting)
Redmile Group, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/28/2023
3:53 PM
Fate Therapeutics (Subject)
Form SC 13D/A
12/28/2023
3:53 PM
Fate Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13D/A
12/18/2023
10:40 AM
Dulac Edward J III (Reporting)
Fate Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/27/2023
11:15 PM
Fate Therapeutics (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FATE) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners